PARPi Triggers the STING-dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness

Cancer Research - United States
doi 10.1158/0008-5472.can-18-1003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune Checkpoint Blockade

Clinical Cancer Research
Cancer ResearchOncology
2018English

Immune Checkpoint Blockade: Subjugation of the Masses

2017English

Immune Checkpoint Blockade in Lymphoid Malignancies

FEBS Journal
BiochemistryCell BiologyMolecular Biology
2016English

Inhibition of QPCTL Induces Myeloid Immune Checkpoint Blockade

Cancer Discovery
Oncology
2019English

Review Article: Immune Checkpoint Inhibitors and the Liver, From Therapeutic Efficacy to Side Effects

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Nodular Regenerative Hyperplasia Associated With Immune Checkpoint Blockade

Hepatology
MedicineHepatology
2018English

Immune Checkpoint Blockade for Hematologic Malignancies: A Review

Stem Cell Investigation
2017English

Role of Tissue-Resident Memory in Intra-Tumor Heterogeneity and Response to Immune Checkpoint Blockade

Frontiers in Immunology
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy